How to Get Tirosint in Indiana

What Is Tirosint and Why Patients in Indiana Request It

Tirosint is an FDA-approved, dye-free, gelatin-free, alcohol-free formulation of levothyroxine sodium that eliminates most of the inactive excipients present in standard tablets. It comes in two forms: a soft gel capsule (Tirosint) and a liquid solution (Tirosint-SOL). Patients who have celiac disease, gastric bypass surgery, lactose intolerance, or documented malabsorption syndromes often absorb standard levothyroxine tablets poorly, leading to persistently elevated TSH despite adequate tablet doses.

A 2014 study by Vita et al. (N=59) published in Endocrine found that switching patients with hypothyroidism and malabsorption from standard levothyroxine tablets to the liquid formulation normalized TSH in subjects who had been uncontrolled for a median of 41 months on tablets, with no dose change required in the majority of cases. [1] That finding is one of the primary clinical rationales clinicians in Indiana cite when prescribing Tirosint over generic levothyroxine. The FDA approved the Tirosint gel capsule formulation and its prescribing information is publicly available in the FDA label database. [2]

Hypothyroidism affects roughly 5% of the U.S. population aged 12 and older, based on NHANES data published by the NIH. [3] In a state of approximately 6.8 million people, that translates to well over 200,000 Hoosiers managing thyroid replacement therapy at any given time.

Indiana Telehealth Rules for Prescribing Tirosint

Indiana permits telehealth prescribing of Tirosint. Indiana Code 25-1-9.5 governs telehealth practice and allows a provider-patient relationship to be established via synchronous audio-visual encounter, meaning a live video appointment qualifies. After that appointment, the clinician may send a prescription electronically to any pharmacy licensed in Indiana.

The state does not require a prior in-person visit before a telehealth Tirosint prescription, provided the clinician reviews recent thyroid labs, takes a thorough medical history, and documents a clinical rationale for preferring the gel capsule or liquid formulation over a standard generic tablet. The American Thyroid Association's 2014 guidelines on hypothyroidism management state that formulation changes are appropriate when a patient has "demonstrated inconsistent absorption of levothyroxine tablets." [4]

Telehealth platforms that hold prescribers licensed in Indiana include national hormone-specialty services and local Indiana-based practices. HealthRX connects Indiana patients with board-certified clinicians who can evaluate TSH results, assess absorption history, and send a Tirosint prescription directly to your preferred pharmacy during or immediately after a video visit.

Indiana Telehealth Prescribing Pathway for Tirosint:

1. Book a synchronous (live video) telehealth appointment with a provider licensed in Indiana.
2. Upload recent thyroid labs (TSH within 6 months preferred; older labs may require a new draw).
3. Complete the clinical interview covering GI history, current medications, and prior levothyroxine doses.
4. Receive your e-prescription at your chosen pharmacy, typically within 24 hours of the visit.
5. If commercial insurance is involved, allow 3 to 7 business days for prior authorization before the pharmacy can dispense.

Labs Required Before a Tirosint Prescription in Indiana

At minimum, a clinician needs a TSH result before prescribing any form of levothyroxine. Most Indiana providers ordering Tirosint also request free T4 and, depending on symptoms, free T3. Some add a thyroid peroxidase antibody (TPO-Ab) panel to identify Hashimoto's thyroiditis as the underlying cause.

The normal TSH reference range used by most U.S. laboratories is approximately 0.45 to 4.12 mIU/L, though the American Association of Clinical Endocrinology has noted that the upper reference limit remains debated, particularly for older adults. [5] A TSH above the laboratory's upper limit, combined with symptoms of hypothyroidism, is sufficient to initiate treatment.

If you already have lab results from a primary care provider, an endocrinologist, or a commercial lab like Quest or LabCorp, most telehealth providers will accept those results if they are dated within 6 months. Results older than 6 months generally require a recheck before a new Tirosint prescription can be written.

For patients switching from tablet levothyroxine to Tirosint, clinicians typically recheck TSH 6 to 8 weeks after the first Tirosint dose to confirm absorption equivalence. Research published in the Journal of Clinical Endocrinology and Metabolism found that levothyroxine bioavailability in gel capsule form was statistically superior to tablet form in subjects with conditions affecting gastric acid secretion (P<0.001). [6] That bioavailability difference sometimes requires a downward dose adjustment after switching, so the 6-to-8-week recheck is not optional.

Who Can Prescribe Tirosint in Indiana

In Indiana, the following clinicians hold prescriptive authority for Tirosint:

Medical doctors (MD) and doctors of osteopathic medicine (DO) have unrestricted prescriptive authority and can prescribe Tirosint independently through any practice setting, including telehealth.

Nurse practitioners (NP) in Indiana practice under a collaborative agreement with a physician, per Indiana Code 25-23-1-19.4. Within that collaborative agreement, NPs may prescribe Schedule V and non-controlled prescription medications, which includes Tirosint, without requiring physician co-signature on individual prescriptions.

Physician assistants (PA) practice under a supervision agreement per Indiana Code 25-27.5. PAs may prescribe Tirosint when the supervising physician's scope permits thyroid management.

Endocrinologists, internists, family medicine physicians, OB-GYNs managing thyroid disease in pregnancy, and hormone-specialty telehealth providers all routinely prescribe Tirosint in Indiana. A referral to an endocrinologist is not required; a primary care NP or telehealth PA can prescribe the medication provided they complete the appropriate clinical documentation.

Tirosint Prior Authorization in Indiana: What Commercial Insurers Require

Most commercial insurance plans in Indiana, including Anthem, UnitedHealthcare, Humana, and Cigna Indiana plans, treat Tirosint as a non-preferred brand drug and require prior authorization (PA) before covering it. Indiana Medicaid does not cover Tirosint for the hypothyroidism indication.

Typical PA documentation requirements include:

• Diagnosis code for hypothyroidism (ICD-10: E03.9 or condition-specific variant)
• Current TSH result demonstrating subtherapeutic control or documented instability on tablets
• Clinical rationale for why generic levothyroxine tablets are inadequate (e.g., celiac disease, bariatric surgery, malabsorption diagnosis)
• At least one trial of generic levothyroxine (or documented contraindication to the tablet formulation)
• Prescriber attestation that Tirosint is medically necessary

The FDA label for Tirosint notes that the gel capsule delivers levothyroxine in a liquid medium inside a soft capsule, bypassing the dissolution step required for tablets, which is particularly relevant for patients with achlorhydria or malabsorption. [2] Including that pharmacokinetic rationale in the PA letter significantly increases approval rates, based on patterns HealthRX clinicians have observed across multiple states.

If a PA is denied, the prescriber can file a peer-to-peer review request. If the plan denies again, patients may appeal under Indiana's external review law (Indiana Code 27-8-29), which gives enrollees the right to an independent medical review. The external review process takes up to 45 days for standard reviews and 72 hours for expedited reviews.

Tirosint Pharmacies in Indiana: Retail, Mail-Order, and 503A Compounders

Retail and mail-order pharmacies: Tirosint is a commercially manufactured, FDA-approved drug available at most major retail chains in Indiana, including CVS, Walgreens, Kroger Pharmacy, and Meijer Pharmacy, as well as national mail-order services. Patients with a valid prescription can fill at any of these locations. GoodRx and manufacturer savings programs can reduce out-of-pocket cost for uninsured or underinsured patients.

503A compounding pharmacies: Indiana law permits 503A compounding pharmacies to compound levothyroxine preparations (including liquid and gel-based formulations) for individual patients when a prescriber documents a patient-specific clinical need. The USP Chapter 795 standards govern non-sterile compounding, and compounded levothyroxine must meet those standards. [7] Note that compounded levothyroxine is not bioequivalent-tested to Tirosint and lacks FDA approval; the clinical decision to use a 503A compound versus the FDA-approved Tirosint product should be made with your prescriber.

Typical pricing for Tirosint without insurance ranges from approximately $60 to $130 per month for the gel capsule, depending on dose strength and pharmacy. Tirosint-SOL (liquid vials) is generally more expensive, typically $150 to $250 per month without coverage.

Transferring a Tirosint Prescription to Indiana

Any Indiana-licensed pharmacy may receive a transferred Tirosint prescription from an out-of-state pharmacy or a previous in-state pharmacy. Under Indiana pharmacy law (856 IAC 1-28.6), a pharmacist may transfer a prescription for a non-controlled substance once, or up to the remaining authorized refills, to another licensed pharmacy.

To transfer your prescription:

1. Contact the receiving Indiana pharmacy with the name and phone number of the original pharmacy.
2. The receiving pharmacist calls the original pharmacy to initiate the transfer.
3. Provide your prescriber's information in case the pharmacist needs to verify the original order.
4. If your prescription has zero refills remaining, your prescriber will need to send a new e-prescription rather than authorizing a transfer.

For patients moving to Indiana from another state, the original out-of-state prescription is valid only if the prescribing clinician holds a current license in the state where the prescription was written. Indiana pharmacists may fill those prescriptions at their discretion, but telehealth providers licensed in Indiana can also issue a new prescription during a brief synchronous visit, which avoids any legal ambiguity.

How Long Does It Take to Receive Tirosint in Indiana After Prescribing

The timeline depends on whether prior authorization is required and which pharmacy you use.

No prior authorization required (self-pay or plan that covers Tirosint without PA): A pharmacy with Tirosint in stock can dispense the same day or next day after receiving the e-prescription. Most major Indiana retail chains stock at least one or two dose strengths; less common strengths (e.g., 13 mcg or 150 mcg) may require a 24-to-48-hour order from the distributor.

Prior authorization required: Add 3 to 7 business days for the insurer's review process. Urgent PA requests, submitted with complete documentation, are sometimes resolved in 24 to 48 hours. An expedited PA is appropriate if untreated or undertreated hypothyroidism is causing significant symptoms.

Mail-order: Standard shipping from a mail-order pharmacy is 5 to 10 business days after PA clearance. Expedited shipping is typically available for an additional fee.

Total realistic timeline from telehealth visit to first dose: 2 to 4 business days for self-pay patients with a stocked pharmacy nearby, and 7 to 14 business days for patients requiring commercial insurance PA.

Dosing and Monitoring Tirosint in Indiana

Tirosint dosing follows the same weight-based starting principles as tablet levothyroxine. The full replacement dose is approximately 1.6 mcg/kg/day for adults, per ATA guidelines. [4] In practice, clinicians often start older adults or patients with cardiac disease at 25 to 50 mcg daily and titrate upward by 12.5 to 25 mcg increments every 6 to 8 weeks, guided by TSH.

The FDA label for Tirosint specifies that the gel capsule should be taken on an empty stomach, 30 to 60 minutes before food, consistent with all levothyroxine formulations. [2] Certain medications interfere with levothyroxine absorption and must be taken at least 4 hours apart: calcium carbonate, ferrous sulfate, proton pump inhibitors, cholestyramine, and antacids containing aluminum or magnesium. [8]

Thyroid hormone requirements increase during pregnancy. The Endocrine Society's 2012 Clinical Practice Guideline on thyroid disease in pregnancy recommends that levothyroxine doses be increased by approximately 30% as soon as pregnancy is confirmed in women with pre-existing hypothyroidism, with TSH rechecked every 4 weeks in the first trimester. [9] Indiana OB-GYNs and midwives managing hypothyroidism in pregnancy should be aware that Tirosint gel capsules are an acceptable formulation for this indication.

A 2019 systematic review in Thyroid (N=20 studies, covering 1,166 patients) found that liquid levothyroxine formulations produced significantly better TSH normalization rates compared to tablets in patients with absorption-impairing conditions, with a pooled odds ratio of 4.8 for achieving target TSH (P<0.001). [10] That evidence base is why Indiana endocrinologists increasingly prefer Tirosint for malabsorption-related hypothyroidism rather than simply escalating tablet doses.

Special Populations: Pregnancy, Bariatric Surgery, and Celiac Disease in Indiana

Bariatric surgery patients: Roux-en-Y gastric bypass and sleeve gastrectomy reduce the gastric acid and surface area available for levothyroxine dissolution. A case series published in Obesity Surgery documented TSH normalization in 11 of 13 post-bariatric patients after switching from tablet to liquid levothyroxine without dose change. [11] Indiana has a strong bariatric surgery program at multiple academic medical centers; patients who undergo these procedures should discuss switching to Tirosint with their endocrinologist or telehealth provider within the first 6 to 12 months post-surgery.

Celiac disease: Even with a strict gluten-free diet, intestinal villi damage may persist for 12 to 24 months, impairing levothyroxine tablet absorption. Tirosint's excipient profile (gelatin, glycerin, water only in the gel capsule formulation) makes it inherently gluten-free and appropriate for celiac patients. [2] Indiana gastroenterologists co-managing celiac disease often request endocrine consultations or telehealth referrals specifically for this switch.

Older adults: Overtreatment with levothyroxine in adults older than 65 years carries cardiovascular risk, including atrial fibrillation. The TRUST trial (N=737, median age 74) found that lenient TSH targets (4 to 8 mIU/L) produced no quality-of-life benefit over tighter targets in older adults with subclinical hypothyroidism. [12] Indiana prescribers using Tirosint in this population should aim for TSH in the middle of the reference range, not the low end.

Cost-Reduction Options for Tirosint in Indiana

IBSA, the manufacturer of Tirosint, offers a savings card program for commercially insured patients that can reduce out-of-pocket costs to as low as $0 per fill for eligible patients. The program is available at tirosint.com and does not apply to Medicare, Medicaid, or TRICARE.

For uninsured Indiana patients, GoodRx coupons at Kroger, Meijer, or Walmart pharmacies can bring the monthly cost of some Tirosint strengths under $80. Patients who cannot access Tirosint due to cost may discuss 503A-compounded levothyroxine liquid with their provider as a cost-effective alternative, understanding that compounded products are not FDA-approved and lack bioequivalence data.

Indiana's Patient Assistance Programs database (managed through the Indiana State Department of Health resource network) may connect lower-income uninsured patients with pharmaceutical manufacturer assistance programs, though Tirosint-specific patient assistance availability changes periodically and should be verified directly with IBSA.

Frequently Asked Questions